Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Acute Kidney Injury | Case report

Norovirus: a novel etiologic agent in hemolytic uremic syndrome in an infant

Authors: Ghadi Abu Daher, Bilal Aoun, Fatima Jaafar, Sarah Khafaja, Sami Sanjad

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Hemolytic uremic syndrome is a rare thrombotic microangiopathy usually seen in infants and children below the age of 5 years. It usually follows a bout of bloody diarrhea caused by Shiga toxin producing E coli and is characterized by microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury. We report the first case of hemolytic uremic syndrome in an infant following Norovirus gastroenteritis.

Case presentation

A nine-month-old male infant, was admitted with an 8-day history of watery, non-bloody diarrhea, vomiting and decreased oral intake. Physical exam revealed normal blood pressure, pallor and generalized edema. Laboratory findings were significant for microangiopathic hemolytic anemia, thrombocytopenia and azotemia. Stool studies with Multiplex Qualitative reverse transcriptase PCR were positive for Norovirus GI/G II. His clinical course was unusually severe, complicated by oligoanuria and worsening uremia requiring peritoneal dialysis but with eventual complete recovery.

Conclusions

To our knowledge this is the first case of Norovirus associated HUS in an infant. Given the ubiquity of this virus as a major cause of diarrhea, together with the increased availability of Multiplex Qualitative PCR in reference laboratories, it is quite possible that we shall be seeing more such cases in the future.
Literature
1.
go back to reference Ardissino G, Salardi S, Colombo E, Testa S, et al. Epidemiology of Haemolytic uremic syndrome in children. Data from the north Italian HUS network. Eur J Pediatr. 2015;175(4):465–73.CrossRef Ardissino G, Salardi S, Colombo E, Testa S, et al. Epidemiology of Haemolytic uremic syndrome in children. Data from the north Italian HUS network. Eur J Pediatr. 2015;175(4):465–73.CrossRef
2.
go back to reference Norris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(4):1035–50.CrossRef Norris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(4):1035–50.CrossRef
3.
go back to reference Trachtman H. HUS and TTP in children. Pediatr Clin of North America. 2013;60(6):1513–26.CrossRef Trachtman H. HUS and TTP in children. Pediatr Clin of North America. 2013;60(6):1513–26.CrossRef
4.
go back to reference Spinale M, Ruebner RL, Copelovitch L, Kaplan BS. Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol. 2013;28(11):2097–105.CrossRef Spinale M, Ruebner RL, Copelovitch L, Kaplan BS. Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol. 2013;28(11):2097–105.CrossRef
5.
go back to reference Garg A, Barrowman N, Matsell D, Suri RS, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA. 2003;290(10):1360–70.CrossRef Garg A, Barrowman N, Matsell D, Suri RS, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA. 2003;290(10):1360–70.CrossRef
6.
go back to reference Da Silva RL. Viral-associated thrombotic microangiopathies. Hematol Oncol Stem Cell Ther. 2011;4(2):51–9.CrossRef Da Silva RL. Viral-associated thrombotic microangiopathies. Hematol Oncol Stem Cell Ther. 2011;4(2):51–9.CrossRef
7.
go back to reference Alpers CE. Light at the end of the TUNEL: HIV associated microangiopathy. Kidney Int. 2003;63:3885–396.CrossRef Alpers CE. Light at the end of the TUNEL: HIV associated microangiopathy. Kidney Int. 2003;63:3885–396.CrossRef
8.
go back to reference Allen U, Licht P. Pandemic H1N1 influenza and atypical HUS-more than just another trigger. Pediatr Nephrol. 2011;23:3–5.CrossRef Allen U, Licht P. Pandemic H1N1 influenza and atypical HUS-more than just another trigger. Pediatr Nephrol. 2011;23:3–5.CrossRef
9.
go back to reference Sugimoto T, Ogawa N, Aoyama M, et al. Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. Nephrol Dial Transplant. 2007;22:2098.CrossRef Sugimoto T, Ogawa N, Aoyama M, et al. Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. Nephrol Dial Transplant. 2007;22:2098.CrossRef
10.
go back to reference Gaur L, Gupta A, Shingada A, Bhalla AK, Gupta A, Malik M, Bhargava V, Rana DS. Norovirus-associated hemolytic uremic syndrome in a renal transplant recipient. Saudi J Kidney Dis Transpl. 2018;29:1519–22.CrossRef Gaur L, Gupta A, Shingada A, Bhalla AK, Gupta A, Malik M, Bhargava V, Rana DS. Norovirus-associated hemolytic uremic syndrome in a renal transplant recipient. Saudi J Kidney Dis Transpl. 2018;29:1519–22.CrossRef
11.
go back to reference Lee BH, Kwak SH, Shin JI, Lee SH, et al. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Pediatr Res. 2009;66:336340. Lee BH, Kwak SH, Shin JI, Lee SH, et al. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Pediatr Res. 2009;66:336340.
12.
go back to reference Togarsimalemath SK, Si-Mohammed A, Puraswani M, Gupta A, Vabret A, et al. Gastrointestinal pathogens in anti-FH antibody positive and negative hemolytic uremic syndrome. Pediatr Res. 2018;84(1):118–24.CrossRef Togarsimalemath SK, Si-Mohammed A, Puraswani M, Gupta A, Vabret A, et al. Gastrointestinal pathogens in anti-FH antibody positive and negative hemolytic uremic syndrome. Pediatr Res. 2018;84(1):118–24.CrossRef
14.
go back to reference Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology. 2006;346:312–23.CrossRef Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology. 2006;346:312–23.CrossRef
15.
go back to reference Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis. 2002;35:246–53.CrossRef Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis. 2002;35:246–53.CrossRef
16.
go back to reference Alberer M, Schlenker N, Bauer M, et al. Detection of gastrointestinal pathogens from stool samples on hemoccult card by multiplex PCR. Canad J of Inf Dis and Med Microbiol. 2017:1–6. Alberer M, Schlenker N, Bauer M, et al. Detection of gastrointestinal pathogens from stool samples on hemoccult card by multiplex PCR. Canad J of Inf Dis and Med Microbiol. 2017:1–6.
17.
go back to reference Thurman JM, Marians R, Emlen W, et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. CJASN. 2009;4:1920–4.CrossRef Thurman JM, Marians R, Emlen W, et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. CJASN. 2009;4:1920–4.CrossRef
18.
go back to reference Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011;26(1):41–57.CrossRef Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011;26(1):41–57.CrossRef
Metadata
Title
Norovirus: a novel etiologic agent in hemolytic uremic syndrome in an infant
Authors
Ghadi Abu Daher
Bilal Aoun
Fatima Jaafar
Sarah Khafaja
Sami Sanjad
Publication date
01-12-2019

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue